the patients were randomized in six groups to receive either 0.5 % bupivacaine-co2 or 0.5 % bupivacaine-hcl at temperatures of 4 degrees , 20 degrees , or 36 degrees c .
C0006400
bupivacaine
C0887621
bupivacaine-hcl